The NIPT test is a non-invasive blood test for pregnant women used to assess the likelihood of certain genetic abnormalities in the fetus. NIPT is performed early in pregnancy and is often recommended in the first trimester, between the 10th and 13th weeks.
The NIPT (Non-Invasive Prenatal Testing) is a non-invasive test performed by taking a simple blood sample from the pregnant mother to analyze fetal DNA present in the mother’s blood.
This test helps with early detection of chromosomal abnormalities such as:
NIPT is usually performed after the 10th week of pregnancy, and is considered one of the most accurate and safest tests for the fetus, as it does not require any surgical intervention and carries no risks like amniocentesis.
Feature | Details |
Non-invasive | Performed by drawing blood from the mother only |
High accuracy | Accuracy exceeds 99% for some conditions such as Down syndrome |
Early results | Results can be obtained from the 10th week of pregnancy |
Safe for the fetus | Does not pose any risk to the fetus |
Condition | Accuracy rate |
Down syndrome | 99%+ |
Edwards syndrome | 97% |
Patau syndrome | 91% |
Sex chromosome syndromes (X and Y) | 90–95% |
Note: NIPT does not replace a confirmed diagnosis if an abnormal result is found, and follow-up with a specialist physician is required.
سيتم التواصل معك من قبل وريد لتاكيد الحجز
سيتم التبرع بجزء من قيمة الفاتورة عبر منصة إحسان قدامك العافية
